Results
10
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
10 companies
Celon Pharma
Market Cap: zł1.3b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł23.80
7D
-3.6%
1Y
42.9%
Selvita
Market Cap: zł662.6m
Operates as a contract research organization worldwide.
SLV
zł36.10
7D
-8.8%
1Y
-48.0%
BIOTON
Market Cap: zł356.3m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.15
7D
4.8%
1Y
17.7%
Mabion
Market Cap: zł163.6m
A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.
MAB
zł10.12
7D
-2.5%
1Y
-43.8%
Poltreg
Market Cap: zł163.2m
A biotechnology company, develops therapies for autoimmune diseases.
PTG
zł35.00
7D
-3.3%
1Y
-26.2%
Biogened
Market Cap: zł77.6m
Develops, produces, and distributes pharmaceutical products in Poland.
BGD
zł31.60
7D
-1.3%
1Y
54.9%
Read-Gene
Market Cap: zł53.3m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł4.52
7D
-0.4%
1Y
-9.2%
Genomed Spólka Akcyjna
Market Cap: zł31.7m
Provides DNA analysis and congenital diseases diagnostic services in Poland.
GEN
zł24.00
7D
-3.2%
1Y
-14.3%
Labocanna
Market Cap: zł7.0m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.33
7D
0.9%
1Y
-18.0%
Stem Cells Spin
Market Cap: zł6.2m
Operates as a biotechnology company in Poland.
SCS
zł0.19
7D
9.3%
1Y
-60.8%